Trudhesa (dihydroergotamine mesylate intranasal) / Impel Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Trudhesa (dihydroergotamine mesylate intranasal) / Impel Pharma
NCT03401346: Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults

Completed
1
36
RoW
INP104, Dihydroergotamine Mesylate (DHE), Migranal Nasal Spray
Impel NeuroPharma Inc.
Migraine Headache
12/17
12/17

Download Options